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ABSTRACT  The  uptake  and  retrograde  transport  of  noradrenaline  (NA)  within  the  axons  of 
sympathetic  neurons  was  investigated  in  an  in  vitro system.  Dissociated  neurons  from  the 
sympathetic ganglia of newborn rats were cultured for 3-6 wk in the absence of non-neuronal 
cells in a culture dish divided into three chambers.  These allowed separate access to the axonal 
networks and to their cell bodies of origin. [3H]NA (0.5 X 10  -e M), added to the axon chambers, 
was  taken  up  by  the  desmethylimipramine-  and  cocaine-sensitive  neuronal  amine  uptake 
mechanisms,  and a substantial part was rapidly transported retrogradely along the axons to the 
nerve cell  bodies. This transport was blocked by vinblastine or colchicine. In contrast with the 
storage of [3H]NA in the axonal varicosities, which was totally prevented by reserpine  (a drug 
that selectively inactivates the uptake of  NA into adrenergic  storage vesicles),  the retrograde 
transport of  [3H]NA was only slightly diminished  by reserpine  pretreatment.  Electron  micro- 
scopic localization of the NA analogue  5-hydroxydopamine  (5-OHDA)  indicated that mainly 
large dense-core  vesicles (700-1,200-A diam) are the transport compartment involved. Whereas 
the majority of small and large vesicles lost their amine dense-core  and were unable to take up 
5-OHDA after reserpine  pretreatment,  the population  of large dense-core  vesicles  and  some 
small  dense-core  vesicles  involved in the retrograde  transport were resistant  to this drug.  It, 
therefore,  seems that these  vesicles  maintained  the  amine  uptake  and  storage  mechanisms 
characteristic for  adrenergic  vesicles,  but  have  lost  the  sensitivity of  their amine  carrier  for 
reserpine.  The  retrograde  transport of  NA and  5-OHDA  probably reflects  the return  of  used 
synaptic vesicle  membrane  to the cell  body in a form  that is distinct from  the membranous 
cisternae  and prelysosomal  structures involved in the retrograde  axonal  transport of extracel- 
lular tracers. 
In general, neither the synthesis nor the degradation of mac- 
romolecular constituents of membranes in particular, occurs in 
the  axons  and  nerve  terminals  of neurons  (5,  16,  27,  28). 
Efficient transport systems are therefore needed to carry newly 
synthesized material from the cell body to the nerve terminals 
and back to the cell body. These transport functions are served 
by  fast  and  slow  anterograde  transport,  and  by  retrograde 
transport, respectively (23, 47, 58).  Rapidly transported mate- 
rial in the anterograde direction is always present inside, or as 
a  constituent  of membranous  organeUes,  mostly vesicles or 
organdies morphologically resembling the smooth endoplas- 
mic reticulum (sER;  [17,  23,  50,  63]).  Organdies  involved in 
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the retrograde transport  are tubular and vesicular structures, 
large  cisternae,  and  prelysosomal  organdies  (multivesicular 
bodies,  cup-shaped  bodies;  [46,  47,  50,  63]).  Although  the 
direction of transport (anterograde or retrograde) for a  given 
organeUe is certainly strictly regulated by the cell, the mecha- 
nisms responsible for the direction taken are unknown. 
Membrane transport from the perikaryon to the nerve ter- 
minal serves two main functions:  (a)  renewal  of the  plasma 
membrane,  involving  the  supply,  e.g.,  of general  structural 
constituents, and of specific receptors for extracellular signals, 
e.g.,  macromolecular  factors,  and  neurotransmitters;  and  (b) 
renewal  of synaptic  vesicles  (23,  28).  Biochemical  evidence 
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aptic vesicle membranes and plasma membranes (15,  34,  65, 
68).  Although temporary fusions take place between the two 
types of membrane during exocytotic transmitter release, vesi- 
cle membrane seems to be retrieved selectively (25, 26, 38, 67). 
Less clear is the origin of synaptic vesicles.  Vesicles,  especially 
large dense-core vesicles in adrenergic or serotoninergic neu- 
rons, are rapidly transported from the cell body to the terminals 
or varicosities (14, 21, 55, 59), and it has been suggested that, 
after an initial exocytosis, their membranes contribute to the 
formation of small dense-core vesicles,  the predominant type 
of vesicle in most adrenergic nerve endings (49).  However, in 
adrenergic neurons, budding of small and large catecholamine- 
storing vesicles from the axonal and terminal ER-like tubular 
network  has  aLso been  observed  (56),  and  a  catecholamine- 
containing reticular network has been observed in axons and 
terminals (56,  61).  In neuromuscular junctions,  synaptic vesi- 
cles can bud from larger membrane cisternae during recovery 
after  massive  stimulation  (25).  It is  not known whether  the 
membrane components of synaptic vesicles and plasma mem- 
branes  are  part  of the  same  organelle  during  anterograde 
transport, or whether they are always separated.  The same is 
true  for  their  retrograde  transport.  In  adrenergic  nerves,  a 
retrograde transport of synaptic vesicle membrane is indicated 
by the accumulation of dopamine-fl-hydroxylase (an enzyme 
involved in the synthesis of NA and located in the membrane 
of synaptic vesicles;  [34])  and of NA not only proximal, but 
also distal to nerve constrictions (4,  14). 
Neuroanatomical tracing experiments in the central nervous 
sytem  have  shown,  surprisingly,  that  some  established  and 
some  putative  neurotransmitters  (glycine,  gamma-aminobu- 
tyric acid [GABA], aspartate,  glutamate, acetylcholine, dopa- 
mine, and serotonin) are selectively taken up by the respective 
nerve terminals and transported retrogradely to the cell bodies 
(1,  12). For  these  small  molecules  to  be  transported  over 
distances of several millimeters,  a  stable storage complex has 
to be formed. Besides the amines, only glycine has been shown 
to be associated with vesicles during anterograde transport, in 
Aplysia neurons (42). The organelles involved in the retrograde 
transport of these transmitter molecules are not yet known. 
Dissociated  rat  sympathetic neurons in a tissue  culture  dish 
divided into  three  chambers (7)  were used to study retrograde 
axonal  transport under  well-defined conditions. Wc  have 
shown that  [3H]NA is  taken up into  the varicositics,  and that 
part of it is transported retrogradcly in reserpine-resistant, 
mainly large,  dense-core vesicles. 
MATERIALS  AND  METHODS 
Culture Procedure:  Polystyrene fLux Scientific Inc., Newbnry Park, 
CA) or  Aclar  (Allied  Chemical Corp.,  Morristown, N J)  coverslips  of  2S-ram  diam 
were glued into  35-mm  tissue  culture dishes (Falcon Labware, Oxnard, CA) 
sterilized  by ultraviolet  irradiation,  and coated with sterile  collagen (calf  skin, 
Sigma Chemical Co., St.  Louis, MO). A  Teflon ring  separating  the dish into  a 
central  chamber for  the  neuron  cell  bodies and  two  side  chambers for  axons  (Fig. 
I  a)  was  sealed  onto  the  coverslip  with  silicon  grease  (Dow Coming high-vacuum 
grease;  Dow Coming Corp.,  Midland, MI) as  described by  Campenot (7). 
Neurons were dissociated  from superior  cervical  ganglia  of  newborn rats  by a 
l-h incubation  in 0A%  trypsin (Sigma Chemical  Co.) and 0.1% collagenase 
(Worthington Biochemical Corp., Freehold, N J)  in  Ca++/Mg++-free phosphate- 
buffered saline  at 37°C, followed by I0  rain  in  0.5% trypsin.  After two washes, 
the ganglia were suspended in l  ml of  complete medium and triturated  with a 
slliconized  Pasteur pipette.  5,DOO-10,DO0 Neurons wcrc plated  into  the  cell  body 
chamber of  each dish and cultured for  3-6 wk in  a 5% CO2 in  air  atmosphere. 
The growth medium was an enriched LI~,  COs-based medium as described by 
Mains and Patterson (39),  containing 50 ng/ml mouse  nerve growth factor, 
prepared according to  the modified method of  Bocchini and Angcletti  (54),  5% 
rat  serum, 0.6  g/IDO ml  Methocel (hydroxymethyl cellulose,  Dow Chemical Co., 
Midland, MI),  penicillin  (1  DO  U/nil),  streptomycin (I  DO/~g/ml; Sigma Chemical 
Co.),  and l0  -s  M  cytosine  arabinoside (Sigma Chemical Co.;  [24]). 
Before the  retrograde  transport  experiments,  the  density  of  the  axonal  networks 
in  the  axon chambers was checked, so  that  only  cultures  with comparable, high 
fiber  densities  were  used.  The  axons  were  washed overnight  in  medium containing 
no Mcthocel,  no cytosine  arabinosidc,  and 0.1% bovine scum  albumin (BSA; 
Sigma Chemical Co.) instead  of  rat  serum (LIs-BSA), to  prevent complex effects 
of  serum  constituents.  For  this  wash,  the  axon  chambers wcrc  filled  with  medium 
to the top,  i.e.,  -3 mm  above the fluid  level  of  the cell  body chamber, which 
enabled leaking  cultures  to  be  detected  and  discarded. 
Retrograde  Transport  of [3 H]  Noradrenaline:  [aHINA (/-7,8- 
[aH]noradrenaline, specific activity 32 or 37 Ci/mmol, Amersham Corp., Radi- 
ochemical Center, Amersham, England; or 44 Ci/mmol, New England Nuclear, 
Boston, MA) was diluted in Lls-BSA medium to a concentration of 0.7 ×  10  -s M 
and added to the axons in  1DO ~l per axon chamber. Cultures were returned to 
the incubator for 6 h. At the end of the experiment, 20/.d of medium was taken 
from each axon chamber and 150 #1 from the slit containing the cell bodies for 
counting. All the remaining medium was then removed and the cell bodies were 
FIGURE  1  Chamber culture arrangement used in the present study  (7).  (a) Teflon  ring with  left and  right axonal chambers and 
central slit for the cell  bodies. (b)  Bottom of culture dish after removing the ring. Clumps of cell bodies in the center give rise to 
bundles of branching axons. Methylene blue stained, x  70, 
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cultures were air-dried, the Teflon ring was removed, and the coverslips were cot 
into left and right axon chambers, and cell body chamber, and the parts counted 
separately. 
The amount of radioactivity in the medium of the cell body chambers at the 
end of the experiment indicated whether leakage occurred above the normal level 
(see below). Data obtained from such cultures were discarded. Due to the care 
that had to be taken in handling the axons and removing the previous medium 
from  the  axon chambers, the  actual concentrations of [Ha]NA in  the  axon 
chambers, as determined for each culture at the end of the experiments, varied 
from 0.3 to 0.6 x  10  -6 M. Since the uptake of [3I-I]NA was linear between 0.3 and 
0.6 x  10  -6 M, the counts obtained from axons and cell bodies were normalized 
to 0.5 x  10  -6 M for each cutture. 
Drug Treatments:  All drugs applied to the axons were diluted in L~;,- 
BSA medium; drugs applied to the neuronal cell bodies were diluted in normal 
growth medium. The following  drugs were added with [:~H]NA to the axons only: 
unlabeled NA (d-, I-NA; Sigma Chemical Co.), 2 x  10  -4 M; desmethylimipramine 
(DMI; Ciba-Geigy Ltd., Basel, Switzerland) 0.7 or 7 x  10  -" M: cocaine, 10  -~ M. 
These drugs were used for preincubations only: reserpine (Sigma Chemical 
Co.), 10 6 M, 45-rain incubation of axons and cell bodies, followed by a  15-rain 
wash with L~r,-BSA (axons) or normal growth medium (cell bodies); tranylcy- 
promine (R6hm Pliarma GmbH, Darmstadt, Federal Republic of Germany), 5 
x  10  -~ M  for 15 min on axons only or axons and cell bodies, followed by two 
washes with Lt6-BSA. 
The following drugs were present during a  preincubation period as well as 
with [:~H]NA in the axon chambers: colchicine (Sigma Chemical Co.), 5 x  10-" 
M  on axons and cell bodies,  l-h preincubation; vinblastine (Sigma Chemical 
Co.),  10  -~' M  on axons and cell bodies,  l-h preincubation; yohimbine (Sigma 
Chemical Co.), 10  -7 M on axons only, 15-min preincubation; I-propranolol (1CI- 
Pharma, Plankstadt, Federal Republic of Germany), 10 7 or 10  -~ M  on axons 
only,  15-min  preincubation;  U-0521  (catechol-o-methyl transferase  [COMT] 
inhibitor, gift of Dr.  H.  B6nisch, Institute  of Pharmacology and Toxicology, 
University of Wiirzburg, Federal Republic of Germany), 5 x  10 ~ M on axons 
and cell bodies, 15-min preincubation. 
Electron Microscopy:  Axons were washed with L~r,-BSA as previously 
described, and incubated for 6 h with 5 x  10  -4 M 5-hydroxydopamine (5-OHDA; 
[5-OHDA  •  HBr]; Hoffmann-La Roche Inc., Basel,  Switzerland) in  Lr,-BSA. 
The incubation solution was renewed after 3  h. Control cultures were treated 
identically but incubated with L~.~-BSA alone. As a control for the specificity of 
the 5-OHDA uptake and labeling, DMI  (7  x  10  -~  M)  was present during the 
tracer incubation. Reserpine pretreatment of axons and cell bodies was carried 
out as described above. Before fixation, the axon chambers were rinsed once with 
Lt~-BSA. 
Glutaraldehyde fixation (3% in 0.1  M  phosphate buffer, pH 7.4) was per- 
formed for  1 h  at room temperature, followed by extensive washes in 0.1  M 
phosphate buffer containing 5% sucrose, postfixation in I% OsO4, block staining 
in uranyl acetate, and embedding in Epon 812. The bichromate-osmium  tetroxide 
fixation was made as described by Tranzer and Richards (62):  Briefly, cultures 
were treated on ice with ice-cold 1% glutaraldehyde, 0.4% formalin in a sodium 
chromate-potassium bichromate buffer, 0.1 M, pH 7.2 for 3 min, and then washed 
and stored overnight in 0.2 M  sodium chromate-potassium bichromate buffer, 
pH  6.0,  at  4°C.  OsO4 (2%)  impregnation was performed  for  1 h  at  4°C  in 
chromate-dichromate  buffer, 0.1 M, pH 7.2, followed by washes in acetate buffer. 
dehydration, and embedding in Epon 812. 
Thin sections were cut from the axons or cell bodies parallel to the surface of 
the tissue culture dish and examined unstained or stained with uranyl acetate 
and lead citrate in a Zeiss EM  10 electron microscope. 
RESULTS 
Cultures 
About 4 d after plating, the first axons penetrated the silicon 
grease  barrier  dividing  the  axon  and  cell  body  chambers. 
Within 2-3  wk, a  dense network of fibers having many vari- 
cosities filled the axon chambers (Fig.  1 b). No non-neuronal 
cells (Schwann  cells or fibroblasts)  were present in the axon 
chambers. In the cell body chambers, the neurons had a strong 
tendency  to aggregate  into variously-sized clumps.  Rarely,  a 
non-neuronal cell on the plastic surface could be seen serving 
as an attachment point for neurons or neuronal aggregates. 
Uptake and Retrograde Transport of 
[ 3  H]Noradrenaline: 
Pharmacological  Characterization 
The addition of[aH]NA (0.5 x  l0 -° M) to the axon chambers 
was followed by uptake into the axons and varicosities and the 
appearance of radioactivity in the cell body chamber (proximal 
axons  and  cell bodies)  within  6  h  (Fig.  2).  The  uptake  and 
transport  of [3H]NA  were blocked by the presence of a  400- 
fold excess of unlabeled  NA or by the disruption of microtu- 
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FIGURE  2  Accumulation 
of  radioactivity  in  axons 
and  cell  bodies  of  sympa- 
thetic neurons  in  chamber 
cultures  during  a  6-h  ex- 
posure  of  their  axons  to 
[3H]NA  (see Materials and 
Methods). Label in the cell 
body  compartments  (/eft) 
reflects  the  retrogradely 
transported  [SH]NA. Spec- 
ificity  of  uptake-transport 
is  shown  by  adding  a 400- 
fold  excess  of  unlabeled 
NA,  Vinblastine  (10  -5  M) 
or  colchicine  (10  -6  M) 
blocked  this  retrograde 
transport. Values represent 
means  +  SEM  of  three  to 
four cultures. 
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colchicine, which also blocked the storage or uptake of [3H]- 
[NA] in the varicosities and axons, vinblastine showed a selec- 
tive effect on the retrograde transport. (The higher nonspecific 
values [i.e.,  in the presence of excess  unlabeled  NA] for the 
axon chambers result largely because rigorous washing was not 
possible: the axons detach easily and would be lost.) Retrograde 
transport  and  accumulation of radioactivity in the cell body 
chamber could already  be  seen  1-2 h  after  adding  [3H]NA 
(data not shown).  Because the minimal distance between the 
uptake  sites  and  the  cell  bodies  was  2-3  mm,  a  minimal 
transport rate of 2-3 mm/h can be estimated. The mean axonal 
length, however, was ~8-12 mm, and the true transport velocity 
may therefore well be higher. 
Inhibition of the NA-degrading enzymes, monoamine oxi- 
dase (MAO) and,  in one experiment,  also COMT by tranyl- 
cypromine and  U-0521,  respectively,  led  to  a  small,  barely 
significant  increase  in  the  amounts  of [ZH]NA  transported 
retrogradely (Fig. 6, MAO blockade). This result indicates that 
the transported radioactivity is [3H]NA rather than a product 
of its metabolism. 
Between 0.1  and  1% of the total radioactivity added to the 
axons was found in the medium of the cell body chamber after 
6 h  of incubation. Whereas a  small part of this radioactivity 
may represent [3H]NA or its metabolic products released from 
the  cell  bodies,  the  larger  part  originated  from  diffusion 
through the silicon grease seal.  We showed that this leaked- 
[3H]NA did not contribute to the specific labeling of the nerve 
cell  bodies  by  directly  adding  0.5  x  10  -s  M  [3H]NA  (the 
maximal  concentration  corresponding  to  that  produced  by 
leakage and release) to the chamber containing the nerve cell 
bodies. The radioactivity accumulated in the cell bodies after 
6  h  was  <5%  of the  values  achieved  following  retrograde 
transport. 
Depolarization of the axons and varicosities by 54 mM K ÷ 
reproducibly led to a  decrease in the amount of retrogradely 
transported [3H]NA, irrespective of whether the depolarization 
occurred 1 h before adding [3H]NA or continuously during the 
incubation  with  [3H]NA  (Fig.  3).  Wheat  germ  agglutinin 
(WGA), a  lectin that binds to specific glycoproteins and gly- 
colipids on the cell surface and that is taken up and transported 
in high amounts by these cells  (M.  Schwab and H. Thoenen, 
in preparation),  seemed  to slightly inhibit  the retrograde  ac- 
cumulation of [aH]NA as well as the local accumulation in the 
axons (Fig. 3). 
Two possibilities existed for the mechanism of the specific 
uptake of [3H]NA by varicosities and axons as a prerequisite 
for retrograde transport: (a) binding of [aH]NA to presynaptic 
a-  or B-receptors  (51)  followed  by internalizing  the  ligand- 
receptor complex; and (b) uptake by the DMI- and cocaine- 
sensitive NA pump in the plasma membrane and transfer into 
the terminal cytoplasm, followed by pumping into the vesicular 
storage compartments (30).  Fig. 4 shows that neither yohim- 
bine, a presynaptic a-blocker, nor L-propranolol, a blocker of 
B-receptors, abolished  the retrograde  transport  of [3H]NA at 
concentrations  that  maximally  block  presynaptic  adrenergic 
receptors (36, 51, 52). In fact, propranolol at 10 -7 M enhanced 
the retrograde accumulation of [3H]NA. In contrast, DMI and 
cocaine, at the concentrations known to be effective from in 
vivo and in vitro experiments (29, 30, 44),  effectively blocked 
the uptake of [3H]NA into the axons and the retrograde accu- 
mulation of [aH]NA in the cell bodies (Fig. 5). To our surprise, 
pretreatment of axons and cell bodies with reserpine (10  -~ M, 
a  saturating  dose  [8,  53]),  a  drug that selectively blocks the 
energy-dependent  uptake  of biogenic amines  such  as dopa- 
mine,  noradrenaline,  adrenaline,  or serotonin from the cyto- 
plasm into the vesicular storage compartments (8, 30, 31, 53), 
did not block the retrograde transport of [3H]NA (Fig. 6). The 
decrease observed in some experiments varied from insignifi- 
cant to a  maximal value of 40%, but was never total.  In the 
same cultures, the terminal and axonal storage of [3H]NA was 
completely  abolished  by reserpine  (Fig.  6).  Identical  results 
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were also obtained with a  higher concentration of reserpine 
(10 -~ M). Additional reserpine treatment of the neuronal cell 
bodies during  the  incubation with  [3H]NA  to  inactivate all 
newly  synthesized vesicles did not  influence  the  retrograde 
transport  either  (data  not  shown).  These  results  were  not 
influenced by pretreatment with the MAO inhibitor, tranylcy- 
promine. Increasing the concentration of [3H]NA in the axon 
chambers to 1.5 x  10 -~ M caused only a minor increase in the 
retrograde accumulation of [3H]NA in the nerve cell bodies, 
although  the  axonal labeling was greatly enhanced  (Fig. 6). 
This  result  seems  to  indicate a  saturation of the  retrograde 
transport compartment, but, because the radioactivity present 
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in the nerve cell bodies probably resulted from an equilibrium 
between the retrograde accumulation and subsequent metab- 
olism  or  release,  this  interpretation  has  to  be  viewed  with 
caution. 
Electron  Microscopic  Observations 
Nontreated  glutaraldehyde-ftxed  cultures  showed  the 
healthy appearance of the neurons under the present culture 
conditions. Most fibers in the axon chambers had many vari- 
cosities, showing bundles of microtubules and the total absence 
of ribosomes. Axosomatic and axodendritic typical asymmetric 
synapses were present in the cell body chambers. 40011 
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rain) with reserpine (10  -° M) with or without tranylcypromine totally abolished the storage of [SH]NA in the axons (right)  but had 
only a minor effect on the [aH] NA transported retrogradely (left). Increasing the concentration of [3H] NA to 1.5 x  10  -0 M indicated 
saturability of the retrograde transport compartment. Values are means +  SEM of three to four cultures. 
The bichromate-osmium tetroxide fixation for demonstrat- 
ing catecholamines (62) revealed endogenous NA and/or do- 
pamine as dense-cores mainly in small and large vesicles. In 
axons  and  cell  bodies,  small  dense-core  vesicles  were  less 
frequent,  whereas  in  varicosities and  synapses,  most  of the 
vesicles were small. In cultures older than 3  wk, varicosities 
and synapses feU into three groups according to the presence 
of dense-core vesicles: (a)  terminals in which  a  majority of 
small vesicles had dense-cores; (b) the majority of terminals in 
which only some (5-20%) small vesicles had dense-cores; and 
(c) terminals with only clear vesicles. This observation, together 
with the  biochemical demonstration of tyrosine hydroxylase 
activity as well as significant amounts of choline acetyltrans- 
ferase  in  these  cultures  (R.  Heumann,  H.  Gnalm,  and  M. 
Schwab, unpublished observations), indicate the presence of 
some largely adrenergic, some largely cholinergic, and a  ma- 
jority  of dual-function  neurons  (35,  41)  under  the  present 
culture conditions. 
Incubation of the axons with 5-OHDA (5 x  10  -4 M), a false 
transmitter that mimics the behavior of NA (but has a  lower 
affinity for the amine uptake system) (60) for 6 h, resulted in 
the  appearance of dense-cores in virtually all the small and 
large vesicles in the axonal varicosities in bichromate-osmium- 
fixed cultures (Fig. 7 a). DMI abolished the 5-OHDA labeling, 
showing that it resulted exclusively from the specific uptake of 
5-OHDA by the neuronal amine uptake mechanism, in spite 
of the high concentration of 5-OHDA used. (Glutaraldehyde 
fixation was not totally adequate for demonstrating all of these 
dense-cores. In most of the 5-OHDA experiments we therefore 
used  bichromate-osmium  tetroxide  fixation,  in  spite  of the 
poorer ultrastructural preservation.)  Many  neurons  in  long- 
term cultures in the presence of rat serum synthesized acetyl- 
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choline in addition to, or instead of catecholamines, but nev- 
ertheless retained the ability for uptake and vesicular storage 
of  NA  or  5-OHDA.  These  results  confirmed  the  detailed 
descriptions of Landis (35), Wakshull et al. (66), and Reichardt 
and Patterson (43).  Tubular or reticulum-like structures con- 
taining 5-OHDA were occasionally seen, in both axons and 
varicosities. In the cell body chamber, the retrogradely trans- 
ported 5-OHDA was reflected by an increase in the frequency 
of large  dense-core vesicles mainly in  the  axons  (Fig.  7 b). 
However, the presence of endogenous catecholamines made a 
clear interpretation of this experimental condition difficult. 
Because the biochemical experiments showed that the ret- 
rograde transport of NA is at the most influenced only slightly 
by reserpine, axons and cell bodies were pretreated with reser- 
pine. This resulted in an almost total disappearance of the dark 
dense-cores  characteristic  of endogenous  catecholamines  in 
small and large vesicles (Fig. 8). Some large vesicles containing 
pale dense-cores, probably of protein, glycoprotein, or peptide 
nature, could still be observed. 
If 5-OHDA was  added for 6  h  to the axons of reserpine- 
pretreated cultures, a  very clear picture emerged: in the non- 
varicose parts of the axons, irrespective of their localization in 
the cell body or axonal chamber, the majority of the labeled 
organdies were large dense-core vesicles of a diameter of 700- 
1200 A  (Fig. 9a, Table I). In addition, some small dense-core 
vesicles and  elongated vesicles contained  5-OHDA, whereas 
none of the larger cisternae, sER-hke structures, or multivesic- 
ular or other prelysosomal bodies did. In the varicosities, some 
small vesicles contained dense-cores in addition to the labeled 
large  vesicles (Fig. 9b).  Their number  was,  however,  lower 
than expected from the total proportion of small versus large 
vesicles (Table I). The number of labeled vesicles per varicosity 
Retrograde Axonal Transport of Noradrenaline  1543 FIGURE  7  (a)  Electron micrograph of a varicosity in an axon chamber after incubation with 5-OHDA.  Most of the small  (arrows) 
and large vesicles show the typical dense cores produced by 5-OHDA.  Bichromate-osmium tetroxide fixation, x  60,000.  (b) Axons 
and varicosity in the cell body chamber showing large and small  (arrows) dense-core vesicles transporting 5-OHDA  retrogradely 
from the axon chamber. Glutaraldehyde fixation, x  25,000. 
FIGURE  8  (a)  Endogenous NA or dopamine in a synapse forms small dense-cores after bichromate-osmium tetroxide fixation, x 
56,000.  (b)  Disappearance of these dense cores by treatment with reserpine, x  74,000. 
1544 FIGURE  9  Reserpine-treated cultures incubated with 5-OHDA. (a) Axon with two large dense-core vesicles transporting 5-OHDA, 
X  124,000.  (b)  Varicosity  with  several  large and  small  (arrow)  dense-core vesicles  containing  5-OHDA.  Bichromate-osmium 
tetroxide fixation, X  117,000. 
TABLE  I 
Organelles Labeled by 5-OHDA in Axons and Varicosities  of Reserpine-pretreated Cultures of Sympathetic Neurons 
Percent of all labeled organelles 
Total No. of 
Large dense-core  Small dense-core  Cultures  labeled 
vesicles  vesicles  Elongate vesicles  analyzed  organelles 
*Axon chambers 
Varicosities  36 +  13  60 +  14.5  4 +  1.7  3  361 
Axons  80 _+ 3.6  17 +  2  3 _+ 2  3  117 
Cell body chambers 
Axons  62 +  6.5  36 _+ 5  2 +  2  3  110 
*Percent of total vesicle population 
Varicosities  11 _  1.2  89 +  1.2  3  1790 
Axons  43 +  1.5  57 +_ 2.5  4  405 
*  5-OHDA  (5 x  10  -4 M, 6 h) was applied  to the axon chamber only. 
Including vesicles labeled  and  unlabeled,  dense-cored and empty. 
was generally small but quite variable. 
In the  cell  bodies the  only labeled  organelles  found were 
large dense-core vesicles.  Cell body labeling was relatively low 
altogether,  suggesting a  rapid transformation of the transport 
organdies (e.g.,  by fusion with lysosomal or Golgi compart- 
ments) leading to the loss of the transported storage complex 
visible by electron microscopy. 
DISCUSSION 
Virtually  all  the  agents  so  far  shown  to  be  transported  by 
retrograde axonal transport have been macromolecular: mate- 
rial endogenous to the cell returning to the cell body from the 
axons and nerve terminals, or macromolecules taken up from 
the extracellular  space (23,  47).  One of the few exceptions is 
found in the brain, where some established or putative neuro- 
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transmitters  (dopamine, serotonin, glycine, GABA, aspartate, 
glutamate,  and acetylcholine) are accumulated by retrograde 
transport in the cell bodies of neurons using the corresponding, 
or a closely related molecule, as transmitter (1, 12). The reasons 
for this selectivity, and above all the compartments in which 
these  low  molecular weight  substances  are  able  to  undergo 
retrograde axonal transport, remain unknown. 
Using a chamber culture system that allowed separate access 
to the axons and cell bodies of  dissociated sympathetic neurons 
in the absence of non-neuronal or target cells (7), we have been 
able to characterize the uptake and retrograde axonal transport 
of [3H]NA and 5-OHDA with regard to their pharmacological 
and morphological properties.  [3H]NA or 5-OHDA applied to 
the  axons  and  varicosities  was  taken  up  by  the  DMI-  and 
cocaine-sensitive amine carrier in the plasma membrane and 
transferred to two different intracellular storage compartments: 
Retrograde Axonal  Transport of Noradrenaline  1545 a reserpine-sensitive one that comprised the large majority of 
the small vesicles  seen under the electron microscope in the 
varicosities,  but  that  also contributed  some large dense-core 
vesicles,  and  a  reserpine-insensitive  compartment.  The latter 
was mainly responsible for the retrograde transport to the cell 
bodies. Electron microscopic localization of 5-OHDA revealed 
mostly large dense-core vesicles but also some small dense-core 
vesicles as this reserpine-resistant transport organelle. The ret- 
rograde transport  velocity for [3H]NA is fast (minimally 2-3 
mm/h) and the retrograde transport was totally abolished by 
the classical blockers of fast anterograde and retrograde trans- 
port, the microtubule-disrupting agents vinblastine and colchi- 
cine. These results exclude passive intra-axonal diffusion of the 
amines as a possible transport mechanism. Since blocking the 
NA-degrading  enzymes  did  not  significantly  influence  our 
results,  the transported radioactivity probably represents intact 
[3HINA. Blockade of presynaptic a- and fl-receptors  by yo- 
himbine and L-propanolol, respectively (5 I), did not decrease 
the retrograde transport of [aH]NA, indicating that the inter- 
nalization  of [3H]NA after binding to a- or fl-receptors and 
subsequent  receptor  down-regulation  is  not  how  [3H]NA is 
taken up and transported (10, 22, 47).  Interestingly, the stim- 
ulation of NA release by 54 mM K ÷ decreased the accumula- 
tion of retrogradely transported [3H]NA, wherease  10  -7 M  L- 
propranolol increased the retrograde accumulation of [3H]NA. 
The stimulation of fl-receptors on adrenergic nerve terminals 
leads to an increase in the subsequent release of NA, and L- 
propranolol, by blocking this positive feedback loop, has been 
shown to lead to a decrease of NA release (36,  51). Whether 
the present results reflect the specific labeling of various intra- 
cellular  pools  of NA  and  how  these  pools  are  related  to 
retrograde transport is unknown. 
Reserpine-resistant  compartments  for NA  have  been  ob- 
served repeatedly in pharmacological studies (3, 18, 20, 30, 57). 
Because it was assumed that all storage vesicles are equal in 
their reserpine-sensitivity, these results were usually attributed 
to  neuronal  extravesicular  binding  sites.  In  the  reserpine- 
treated perfused rabbit heart, this compartment was shown to 
be saturable and to take up NA with a higher affinity than the 
cocaine-sensitive  pump  in  the  plasma  membrane  (3).  The 
present results clearly show that a reserpine-resistant compart- 
ment is responsible for the retrograde transport of [3H]NA and 
5-OHDA, which is  represented  by a  subpopulation  of large 
vesicles  (700-1200 A) that,  upon loading with 5-OHDA, be- 
come dense-cored. In addition, a few small vesicles (300-600 
,~) in the varicosities (and rarely also in axons) are consistently 
resistant to reserpine pretreatment.  These results confirm two 
earlier  reports  of reserpine-resistant  retrograde  transport  of 
biogenic amines in the central nervous system (1, 64).  Dopa- 
mine injected into the caudate nucleus of reserpine-treated rats 
accumulated  rapidly  in  the  dopaminergic  cell  bodies of the 
substrate nigra (64), and the fast, colchicine-sensitive retrograde 
transport of [3H]serotonin from the olfactory bulb to the raphe 
nuclei was diminished by only 40% by reserpine pretreatment 
(1).  In contrast, no retrograde accumulation of ['~H]serotonin 
was  detectable  after  blockade  of the  neuronal  uptake  with 
fluoxetine, analogous to our results with DMI and cocaine in 
the adrenergic neurons (1). 
The membrane of amine storage vesicles  in adrenal medulla 
and adrenergic nerves is characterized by an energy-dependent 
carrier capable of transporting amines (e.g., dopamine, adren- 
aline,  and  serotonin)  from  the  cytoplasm  into  the  vesicles 
against  a  steep  concentration gradient  (30,  32-34,  68).  This 
amine carrier is inactivated by reserpine  (8,  31,  53).  Because 
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reserpine  is  highly lipophilic,  this  inactivation  is  irreversible 
under physiological conditions (31).  In addition,  there  is  an 
ATP carrier also driven by the proton gradient that is produced 
by a  Mg~+-activated ATPase (68).  ATP, together with  Ca  ++, 
have an important function in forming the intravesicular stor- 
age complex for the amines (8, 34, 68). These components are 
essential for an organelle able to store and transport [3H]NA or 
5-OHDA. Dopamine fl-hydroxylase is another important com- 
ponent of adrenal  medullary granules and at  least  the large 
vesicles from adrenergic nerves (33, 34, 68). All these macro- 
molecular constituents of synaptic vesicle membranes are syn- 
thesized in the cell bodies and supplied to the terminals by fast 
axonal transport (23). In the case of adrenergic nerves, indica- 
tions for their return to the cell body by retrograde transport 
came from two different observations: Early in the study of 
axonal transport  accumulation of endogenous NA was seen 
not only proximal but also distal to nerve ligations (13).  Later 
it was demonstrated that dopamine-fl-hydroxylase also accu- 
mulates distal to ligations (4, 40) and that antibodies to dopa- 
mine-fl-hydroxylase  are  taken  up  selectively  by  adrenergic 
nerve terminals and transported by retrograde transport to the 
corresponding cell  bodies  (19,  48,  69).  Most  interestingly,  a 
large part of this retrogradely transported dopamine-fl-hydrox- 
ylase  is  enzymatically inactive,  in  contrast  with  the  antero- 
gradely  transported  enzyme  in  the  same  axons  (40).  This 
indicates  that  local modifications of components of synaptic 
vesicles  occur  in  the  nerve  terminals  and  may  be  a  direct 
analogy to our finding of resistance  to reserpine.  Instead  of 
assuming a  vesicle type with  amine transport  characteristics 
totally different from the classical reserpine-sensitive ones, loss 
of reserpine sensitivity could be the result of a local modifica- 
tion of the vesicle membrane. Strong indications for such local 
modifications of axonal proteins in target regions were revealed 
by a two-dimensional gel electrophoresis analysis of fast-trans- 
ported  proteins  in  the  rabbit  optic  system  (45).  A  protein 
(protein C, apparent mol wt 20,000)  was found to shift its pI 
by 1 pH U in the lateral geniculate nucleus and by 2 pH U  in 
the optic tectum as compared with  its  pI in the optic nerve. 
Such local modifications are attractive candidates for a signal 
for retrograde  transport.  What  determines  why a  particular 
vesicle or organelle is transported anterogradely or retrogradely 
in an axon has remained enigmatic up to now. 
In accordance with in vivo and in vitro observations (56, 61) 
we also found that large dense-core vesicles  are not the only 
organelles in the axons containing catecholamines or capable 
of accumulating them. Small dense-core vesicles and elongated 
and tubular structures are also present,  although in the vari- 
cosities small vesicles clearly represent the most common amine 
storage compartments (90% in our cultured cells).  Formation 
of vesicles  by budding from reticular or tubular structures, or 
formation of small vesicles from the membrane of large dense- 
core vesicles has been suggested mainly on the basis of electron 
microscopic observations (49, 56, 61).  In the case of the large 
dense-core vesicles  engaged in retrograde transport  shown in 
this  study,  their  origin  in  the  nerve  terminals  could  not  be 
decided. 
Extracellular  macromolecules taken up by nerve terminals 
are transported  retrogradely in large cisternae,  tubular struc- 
tures, or cup-shaped or multivesicular prelysosomal bodies (2, 
6,  11, 23, 37, 46, 47,  63). This has been observed in many in 
vivo and in vitro situations,  and is also true  for sympathetic 
neurons growing in chamber cultures (9; [M. Schwab and H. 
Thoenen,  in  preparation]).  These  compartments  are  clearly 
different from the vesicles transporting  NA or 5-OHDA, re- flecting their different origin and function and probably  also 
the different biochemical properties of their surrounding mem- 
branes. We would like to conclude that the vesicles transporting 
NA and 5-OHDA represent synaptic vesicle membrane return- 
ing to the cell body in the process of synaptic vesicle turnover. 
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